Physician profile
Bradley E Davis
NPI 1811989585
$3,211.73
in general payments reported to CMS, 2019-2025
23 companies · $521 in 2025
The $521 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $327 · 2020: $14.63 · 2021: $291 · 2022: $1,132 · 2023: $844 · 2024: $80.93 · 2025: $521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $733 · Food and Beverage: $713.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $732.95 |
| Food and Beverage | $713.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,953.58 | 2021-2025 | Urolift, Barrigel |
| Procept Biorobotics Corporation | $312.36 | 2025 | |
| Boston Scientific Corporation | $134.04 | 2022 | |
| Abbvie INC. | $82.43 | 2019-2022 | |
| Agiliti Surgical, INC. | $79.29 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $72.49 | 2019-2023 | Bard Urinary Drainage Bag |
| Olympus America INC. | $66.90 | 2019-2025 | Itind System |
| Astellas Pharma US INC | $57.46 | 2020-2023 | Xtandi |
| Coloplast Corp | $54.67 | 2019-2023 | Speedicath |
| Janssen Biotech, INC. | $49.83 | 2019-2022 | |
| Dendreon Pharmaceuticals LLC | $49.83 | 2019 | |
| Ambu INC. | $47.85 | 2024-2025 | |
| Pfizer INC. | $47.18 | 2019 | |
| Rochester Medical Corporation | $30.00 | 2019 | |
| 180 Medical, INC. | $28.23 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Profound Medical Corp. | $21.90 | 2021 | |
| Blue Earth Diagnostics | $20.35 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.29 | 2024 | Entyvio |
| Tolmar Pharmaceuticals, INC. | $19.88 | 2022 | |
| Allergan, INC. | $17.62 | 2019 | |
| Neotract INC. | $16.26 | 2019 | |
| Tolmar, INC. | $15.45 | 2023 | |
| Ferring Pharmaceuticals INC. | $13.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.